|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-5-9
|
|
pubmed:abstractText |
Novel stents loaded with an integrin-binding cyclic Arg-Gly-Asp peptide (cRGD) were analyzed for their potential to limit coronary neointima formation and to accelerate endothelialization by attracting endothelial progenitor cells (EPCs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
pubmed-author:AstafievaIrinaI,
pubmed-author:BernhagenJürgenJ,
pubmed-author:BlindtRüdigerR,
pubmed-author:BosserhoffAnja-KatrinAK,
pubmed-author:DeworManfredM,
pubmed-author:FachChristianC,
pubmed-author:HanrathPeterP,
pubmed-author:HoffmannRainerR,
pubmed-author:HristovMihailM,
pubmed-author:KapurniotuAphroditeA,
pubmed-author:KrottNicoleN,
pubmed-author:KwokConnieC,
pubmed-author:SeitzBertholdB,
pubmed-author:VogtFelixF,
pubmed-author:WeberChristianC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
2
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1786-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16682302-Animals,
pubmed-meshheading:16682302-Cell Adhesion,
pubmed-meshheading:16682302-Cell Movement,
pubmed-meshheading:16682302-Cells, Cultured,
pubmed-meshheading:16682302-Coated Materials, Biocompatible,
pubmed-meshheading:16682302-Coronary Restenosis,
pubmed-meshheading:16682302-Coronary Vessels,
pubmed-meshheading:16682302-Endothelial Cells,
pubmed-meshheading:16682302-Endothelium, Vascular,
pubmed-meshheading:16682302-Hyperplasia,
pubmed-meshheading:16682302-Peptides, Cyclic,
pubmed-meshheading:16682302-Stem Cells,
pubmed-meshheading:16682302-Stents,
pubmed-meshheading:16682302-Swine,
pubmed-meshheading:16682302-Tunica Intima
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
|
|
pubmed:affiliation |
Department of Cardiology, University Hospital Aachen, Aachen, Germany. ruediger.blindt@post.rwth-aachen.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
